4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-25-002100
President & CEO acquired 128,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Warmuth Markus President & CEO | 2025-01-02 | Grant or award | +128,000 | 544,538 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Warmuth Markus President & CEO | 2025-01-02 | Grant or award · Stock Option (Right to Buy) | +575,000 | 575,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…